Chemomab Therapeutics Statistics
Total Valuation
CMMB has a market cap or net worth of $10.94 million. The enterprise value is $3.12 million.
| Market Cap | 10.94M |
| Enterprise Value | 3.12M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMMB has 7.20 million shares outstanding. The number of shares has increased by 38.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 7.20M |
| Shares Change (YoY) | +38.23% |
| Shares Change (QoQ) | +2.02% |
| Owned by Insiders (%) | 11.18% |
| Owned by Institutions (%) | 8.77% |
| Float | 6.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.31
| Current Ratio | 10.31 |
| Quick Ratio | 10.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.61% and return on invested capital (ROIC) is -46.36%.
| Return on Equity (ROE) | -70.61% |
| Return on Assets (ROA) | -40.25% |
| Return on Invested Capital (ROIC) | -46.36% |
| Return on Capital Employed (ROCE) | -74.15% |
| Weighted Average Cost of Capital (WACC) | 7.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.48M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.96% in the last 52 weeks. The beta is 0.64, so CMMB's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -66.96% |
| 50-Day Moving Average | 1.76 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 42.90 |
| Average Volume (20 Days) | 280,307 |
Short Selling Information
The latest short interest is 143,144, so 2.04% of the outstanding shares have been sold short.
| Short Interest | 143,144 |
| Short Previous Month | 134,275 |
| Short % of Shares Out | 2.04% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.93M |
| Pretax Income | -7.45M |
| Net Income | -7.45M |
| EBITDA | -7.86M |
| EBIT | -7.93M |
| Earnings Per Share (EPS) | -$1.07 |
Balance Sheet
The company has $8.04 million in cash and n/a in debt, with a net cash position of $8.04 million or $1.12 per share.
| Cash & Cash Equivalents | 8.04M |
| Total Debt | n/a |
| Net Cash | 8.04M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 10.70M |
| Book Value Per Share | 1.49 |
| Working Capital | 10.36M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 74,250 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.23% |
| Shareholder Yield | -38.23% |
| Earnings Yield | -66.71% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CMMB is $15.00, which is 886.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.00 |
| Price Target Difference | 886.84% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.
| Last Split Date | Aug 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |